NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.1 Cytotoxic drugs > 8.1.5 Other antineoplastic drugs > Melanoma (stage III or IV) - ipilimumab - NICE TAG TA268

Melanoma (stage III or IV) - ipilimumab - NICE TAG TA268

1.1 Ipilimumab is recommended as an option for treating advanced (unresectable or metastatic) melanoma in people who have received prior therapy, only if the manufacturer provides ipilimumab with the discount agreed in the patient access scheme.

https://www.nice.org.uk/guidance/TA268

Site by Devopa
© Copyright 2019 NHS. All rights reserved.